224 related articles for article (PubMed ID: 8740452)
1. Activation of serotonergic 5-HT1A receptor reduces Ca(2+)- and glutamatergic receptor-evoked arachidonic acid and No/cGMP release in adult hippocampus.
Strosznajder J; Chalimoniuk M; Samochocki M
Neurochem Int; 1996 Apr; 28(4):439-44. PubMed ID: 8740452
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide responsible for NMDA receptor-evoked inhibition of arachidonic acid incorporation into lipids of brain membrane.
Samochocki M; Chalimoniuk M; Strosznajder J
Mol Chem Neuropathol; 1996 Sep; 29(1):79-92. PubMed ID: 8887942
[TBL] [Abstract][Full Text] [Related]
3. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide.
Chalimoniuk M; Strosznajder JB
Mol Chem Neuropathol; 1998; 35(1-3):77-95. PubMed ID: 10343972
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices.
Stepień A; Chalimoniuk M; Strosznajder J
Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104
[TBL] [Abstract][Full Text] [Related]
5. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.
Maura G; Marcoli M; Pepicelli O; Rosu C; Viola C; Raiteri M
Br J Pharmacol; 2000 Aug; 130(8):1853-8. PubMed ID: 10952674
[TBL] [Abstract][Full Text] [Related]
6. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion.
Pu S; Xu B; Kalra SP; Kalra PS
Endocrinology; 1996 May; 137(5):1949-55. PubMed ID: 8612535
[TBL] [Abstract][Full Text] [Related]
7. Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro.
Maura G; Raiteri M
J Neurochem; 1996 Jan; 66(1):203-9. PubMed ID: 8522955
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptor-mediated cGMP synthesis in primary cultures of mouse cerebellar granule cells appears to involve neuron-astrocyte communication with NO operating as the intercellular messenger.
Malcolm C; Grieve A; Ritchie L; Schousboe A; Griffiths R
J Neurosci Res; 1996 Jul; 45(2):129-42. PubMed ID: 8843030
[TBL] [Abstract][Full Text] [Related]
9. Regulatory role of nitric oxide over hippocampal 5-HT release in vivo.
Segieth J; Pearce B; Fowler L; Whitton PS
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):302-6. PubMed ID: 11284445
[TBL] [Abstract][Full Text] [Related]
10. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role.
Kendrick KM; Guevara-Guzman R; de la Riva C; Christensen J; Ostergaard K; Emson PC
Eur J Neurosci; 1996 Dec; 8(12):2619-34. PubMed ID: 8996812
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors.
Marcoli M; Cervetto C; Paluzzi P; Guarnieri S; Raiteri M; Maura G
Neurochem Int; 2006 Jul; 49(1):12-9. PubMed ID: 16469416
[TBL] [Abstract][Full Text] [Related]
12. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences.
Fedele E; Conti A; Raiteri M
Neuropharmacology; 1997 Oct; 36(10):1393-403. PubMed ID: 9423927
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide in retina: relation to excitatory amino acids and excitotoxicity.
Zeevalk GD; Nicklas WJ
Exp Eye Res; 1994 Mar; 58(3):343-50. PubMed ID: 7513649
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor-mediated arachidonic acid release in neurons: role in signal transduction and pathological aspects.
Lazarewicz JW; Salinska E; Wroblewski JT
Adv Exp Med Biol; 1992; 318():73-89. PubMed ID: 1386178
[TBL] [Abstract][Full Text] [Related]
15. Serotonin, a potent modulator of arachidonic acid turnover, interaction with glutamatergic receptor in brain cortex.
Strosznajder J; Samochocki M; Duran M
Neurochem Int; 1994 Aug; 25(2):193-9. PubMed ID: 7994200
[TBL] [Abstract][Full Text] [Related]
16. Roles for nitric oxide as an intra- and interneuronal messenger at NMDA release-regulating receptors: evidence from studies of the NMDA-evoked release of [3H]noradrenaline and D-[3H]aspartate from rat hippocampal slices.
Jones NM; Loiacono RE; Beart PM
J Neurochem; 1995 May; 64(5):2057-63. PubMed ID: 7536805
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway.
East SJ; Garthwaite J
Neurosci Lett; 1991 Feb; 123(1):17-9. PubMed ID: 1648186
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor-dependent nitric oxide and cGMP synthesis in brain hemispheres and cerebellum during reperfusion after transient forebrain ischemia in gerbils: effect of 7-Nitroindazole.
Chalimoniuk M; Strosznajder J
J Neurosci Res; 1998 Dec; 54(5):681-90. PubMed ID: 9843159
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice.
Kim HS; Son YR; Kim SH
Life Sci; 1999; 64(26):2463-70. PubMed ID: 10403505
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibitor decreases NMDA-induced elevations of extracellular glutamate and intracellular Ca2+ levels via a cGMP-independent mechanism in cerebellar granule neurons.
Oh S; Yun BS; Ryoo IJ; McCaslin PP; Yoo ID
Arch Pharm Res; 1999 Feb; 22(1):48-54. PubMed ID: 10071959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
